Skip to content

Drug interactions

Maprotiline + Olodaterol inhaled

Severity: Moderate

Maprotiline and Olodaterol inhaled: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Maprotiline can prolong the QT interval, and tricyclic-type antidepressants can potentiate the cardiovascular effects of beta2 agonists such as olodaterol. This may increase the risk of tachycardia and ventricular arrhythmia.

What this interaction means in plain words

Maprotiline and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive QT prolongation and pharmacodynamic potentiation of beta2-agonist cardiovascular effects.

What to do

Monitor heart rate, ECG and potassium in patients with cardiac disease or other QT risk factors. Consider alternative therapy if QTc prolongation or arrhythmia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Olodaterol inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Olodaterol inhaled?

MediHelp rates the interaction as moderate. Maprotiline and Olodaterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Maprotiline can prolong the QT interval, and tricyclic-type antidepressants can potentiate the cardiovascular effects of beta2 agonists such as olodaterol. This may increase the risk of tachycardia and ventricular arrhythmia.

How serious is the interaction between Maprotiline and Olodaterol inhaled?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, ECG and potassium in patients with cardiac disease or other QT risk factors. Consider alternative therapy if QTc prolongation or arrhythmia occurs.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in